Sorry, you need to enable JavaScript to visit this website.
  1. Home
  2. Our Science
  3. Clinical Trials
  4. Plain Language Study Results Summaries

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries, also called plain language summaries, simple summaries, and trial results summaries, are intended to make clinical results understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

A Study to Evaluate the Safety of Dacomitinib for the First Line Treatment of Participants in India With Metastatic Non-Small-Cell Lung Cancer (NSCLC) With Change in a Gene
Category & Conditions: Cancer
Study Phase : 4
Medicine: VIZIMPRO® TABLETS(DACOMITINIB)
Language: English
ViewDownloadPrint
Een studie met enkele dosis om twee tafamidistabletformuleringen te testen bij gezonde volwassen deelnemers
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 1
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: Dutch
ViewDownloadPrint
A Single Dose Study to Test Two Tafamidis Tablet Formulations in Healthy Adult Participants
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 1
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: English
ViewDownloadPrint
Étude à dose unique visant à tester deux formules de comprimés de tafamidis chez des participants adultes en bonne santé
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 1
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: French
ViewDownloadPrint
Eine Einzeldosisstudie zur Untersuchung von zwei Tablettentormulierungen bei gesunden erwachsenen Teilnehmende
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 1
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: German
ViewDownloadPrint
A Trial to Measure the Safety and Efficacy of Vyndaqel Treatment in Patients With Transthyretin Amyloid Cardiomyopathy
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: English
ViewDownloadPrint
Safety And Efficacy Evaluation Of Fx-1006A In Subjects With Transthyretin Amyloidosis
Category & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: English
ViewDownloadPrint
Does tafamidis help treat patients with transthyretin amyloid cardiomyopathy?
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: English
ViewDownloadPrint
Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy
Category & Conditions: Cardiovasular Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
Language: English
ViewDownloadPrint
Study Investigating the Safety and Tolerability of Different Doses of Crizotinib in Participants with Advanced Cancers.
Category & Conditions: Cancer
Study Phase : 1
Medicine: XALKORI®(CRIZOTINIB)
Language: English
ViewDownloadPrint
Study to Learn About the Safety and Effectiveness of Crizotinib in Participants With Tumors, Except Non-Small Cell Lung Cancer, That Are Positive for Anaplastic Lymphoma Kinase (ALK)
Category & Conditions: Cancer
Study Phase : 1
Medicine: XALKORI®(CRIZOTINIB)
Language: English
ViewDownloadPrint
Efficacy Study of Crizotinib in East Asian Patients With ROS1-Positive, ALK-Negative Advanced NSCLC
Category & Conditions: Cancer
Study Phase : 2
Medicine: XALKORI®(CRIZOTINIB)
Language: English
ViewDownloadPrint